The emerging roles of long non-coding RNA in gallbladder cancer tumorigenesis

Cancer Biomarkers : Section a of Disease Markers
Bing ChenFeng Xu

Abstract

Accumulating evidence suggests that long non-coding RNAs (lncRNAs) have important regulatory functions in gallbladder cancer (GBC) tumorigenesis and can serve as potential novel markers and/or targets for GBC. In this review, we critically discuss the emerging alteration of lncRNAs in GBC, the lncRNAs induced epigenetic regulation, the interaction of lncRNAs with microRNAs and lncRNAs effects on tumor-related signaling pathways. Additionally, contributions of lncRNAs in epithelial-mesenchymal transition process and energy metabolism reprogramming in GBC are also addressed. This may pave new ways towards the determination of GBC pathogenesis and lead to the development of new preventive and therapeutic strategies for GBC.

References

Feb 26, 2009·Cell·Chris P PontingWolf Reik
May 21, 2010·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Anne GaboryLuisa Dandolo
Mar 7, 2012·Journal of Molecular Endocrinology·Yunli ZhouAnne Klibanski
Nov 21, 2012·Journal of Translational Medicine·Bing ChenShufang Liang
May 23, 2013·RNA Biology·Lina MaZhang Zhang
Jun 1, 2013·Nature Reviews. Drug Discovery·Claes Wahlestedt
Mar 22, 2014·Journal of Gastrointestinal Cancer·Charlotte Maplanka
Apr 18, 2014·Epigenetics : Official Journal of the DNA Methylation Society·Veronica J Peschansky, Claes Wahlestedt
Jan 3, 2015·Nature Reviews. Genetics·Daniel Holoch, Danesh Moazed
Feb 6, 2015·International Journal of Molecular Sciences·Victoria E Villegas, Peter G Zaphiropoulos
Jan 25, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Shou-Hua WangZhi-Wei Quan
Jan 27, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Bo LiuWei-Dong Chen
Mar 12, 2016·Cancer Letters·Ailin ZhangHong Yang
May 2, 2016·Gene·Dinesh Singh Tekcham, Pramod Kumar Tiwari
Sep 7, 2016·Biochemical and Biophysical Research Communications·Xiang-Zhen KongXiao-Jian Zhang
Oct 8, 2016·Journal of Experimental & Clinical Cancer Research : CR·Shou-Hua WangZhi-Wei Quan
Oct 25, 2016·Cell Chemical Biology·Yue LiHiroshi Sugiyama
Nov 5, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Fei MaJun Ding
Nov 30, 2016·Biochimie·Akanksha KhandelwalAklank Jain
Dec 3, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Dongli ZhangYanyun Li
Feb 9, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Fei MaZhi-Wei Quan
Feb 12, 2017·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·C ZhengJ Shao
Apr 27, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Feng Xu, Jing Zhang
May 4, 2017·Cell Proliferation·Yang YuLin Miao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Related Papers

International Journal of Molecular Sciences
Nina Hauptman, Damjan Glavač
BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology
Zhen-Dong XiaoBoyi Gan
© 2022 Meta ULC. All rights reserved